EBM Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, Z.
Right arrow Articles by Lo, S.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, Z.
Right arrow Articles by Lo, S.-C.
Experimental Biology and Medicine 226:753-757 (2001)
© 2001 Society for Experimental Biology and Medicine


ORIGINAL ARTICLE

Telomerase Activity in Kaposi's Sarcoma, Squamous Cell Carcinoma, and Basal Cell Carcinoma

Ziping Chen*, Kathleen J. Smith{ddagger}, Henry G. Skelton, III§, Terry L. Barrett||, Herbert T. Greenway, Jr. and Shyh-Ching Lo{dagger},1

* American Registry of Pathology and
{dagger} Armed Forces Institute of Pathology, Washington, District of Columbia 20306;
{ddagger} National Naval Medical Center, Bethesda, Maryland 20889;
§ Laboratory Corporation of America, Herndon, Virginia 20171;
|| Johns Hopkins Medical Center, Baltimore, Maryland 21287;
Scripps Clinic, La Jolla, California 92037

Patients with acquired immune deficiency syndrome (AIDS) often develop Kaposi's sarcoma (KS), an unusual skin tumor. The malignant nature of KS has long been disputed. Telomerase activity that maintains telomere length and ensures chromosomal stability, a frequently appearing marker in human malignancies, has been proposed to play a critical role in supporting continued cell growth, hence formation of tumors. We examined telomerase activity in tissue extracts from 22 KS, 10 squamous cell carcinoma (SCC), and 22 basal cell carcinoma (BCC) using the telomeric repeat amplification protocol (TRAP). All of the tumor tissues were previously cryopreserved at -80°C. In this study, all tumor samples tested were positive for telomerase activity. Consistent with the presence of the enzyme activity, the skin tumors had relatively long telomeres. Inhibitors in the tissue extracts of some samples needed to be diluted or extracted by phenol before the enzyme activity was detected in the TRAP assay. All KS as well as two other skin carcinoma samples revealed positive telomerase activity. Our finding supports telomerase's role in tumor cell immortality and suggests the true neoplastic nature of KS.

Key Words: telomerase • Kaposi's sarcoma • malignancy




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
L. Fragnet, E. Kut, and D. Rasschaert
Comparative Functional Study of the Viral Telomerase RNA Based on Natural Mutations
J. Biol. Chem., June 24, 2005; 280(25): 23502 - 23515.
[Abstract] [Full Text] [PDF]


Home page
Arch DermatolHome page
K. K. Sra, M. Babb-Tarbox, S. Aboutalebi, P. Rady, G. L. Shipley, D. D. Dao, and S. K. Tyring
Molecular Diagnosis of Cutaneous Diseases
Arch Dermatol, February 1, 2005; 141(2): 225 - 241.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
L. Fragnet, M. A. Blasco, W. Klapper, and D. Rasschaert
The RNA Subunit of Telomerase Is Encoded by Marek's Disease Virus
J. Virol., May 15, 2003; 77(10): 5985 - 5996.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the Society for Experimental Biology and Medicine.